Ajanta Pharma (India) Price History
AJANTPHARM | 3,027 30.05 1.00% |
Below is the normalized historical share price chart for Ajanta Pharma Limited extending back to July 01, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ajanta Pharma stands at 3,027, as last reported on the 28th of November, with the highest price reaching 3,040 and the lowest price hitting 2,950 during the day.
If you're considering investing in Ajanta Stock, it is important to understand the factors that can impact its price. Ajanta Pharma Limited secures Sharpe Ratio (or Efficiency) of -0.0339, which signifies that the company had a -0.0339% return per unit of standard deviation over the last 3 months. Ajanta Pharma Limited exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Ajanta Pharma's mean deviation of 1.74, and Risk Adjusted Performance of 0.0017 to double-check the risk estimate we provide.
As of now, Ajanta Pharma's Total Stockholder Equity is increasing as compared to previous years. The Ajanta Pharma's current Liabilities And Stockholders Equity is estimated to increase to about 48.7 B, while Common Stock Shares Outstanding is projected to decrease to under 104.9 M. . Ajanta Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 2.6 K | 50 Day MA 3.1 K | Beta 0.104 |
Ajanta |
Sharpe Ratio = -0.0339
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | AJANTPHARM |
Estimated Market Risk
2.17 actual daily | 19 81% of assets are more volatile |
Expected Return
-0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ajanta Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ajanta Pharma by adding Ajanta Pharma to a well-diversified portfolio.
Price Book 10.1803 | Enterprise Value Ebitda 27.6695 | Price Sales 8.3497 | Shares Float 42 M | Dividend Share 54 |
Ajanta Pharma Stock Price History Chart
There are several ways to analyze Ajanta Stock price data. The simplest method is using a basic Ajanta candlestick price chart, which shows Ajanta Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 10, 2024 | 3395.67 |
Lowest Price | November 13, 2024 | 2824.9 |
Ajanta Pharma November 28, 2024 Stock Price Synopsis
Various analyses of Ajanta Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Ajanta Stock. It can be used to describe the percentage change in the price of Ajanta Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Ajanta Stock.Ajanta Pharma Price Daily Balance Of Power | 0.34 | |
Ajanta Pharma Price Rate Of Daily Change | 1.01 | |
Ajanta Pharma Accumulation Distribution | 1,057 | |
Ajanta Pharma Market Facilitation Index | 0 | |
Ajanta Pharma Price Action Indicator | 46.60 |
Ajanta Pharma November 28, 2024 Stock Price Analysis
Ajanta Stock Price History Data
The price series of Ajanta Pharma for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 570.77 with a coefficient of variation of 5.22. The prices are distributed with arithmetic mean of 3111.23. The median price for the last 90 days is 3120.66. The company had 3:2 stock split on 22nd of June 2022. Ajanta Pharma Limited issued dividends on 2024-11-06.Open | High | Low | Close | Volume | ||
11/27/2024 | 2,992 | 3,040 | 2,950 | 3,027 | 35,909 | |
11/26/2024 | 2,990 | 3,044 | 2,972 | 2,997 | 41,320 | |
11/25/2024 | 2,975 | 3,100 | 2,960 | 2,997 | 135,071 | |
11/22/2024 | 2,945 | 3,007 | 2,937 | 2,960 | 57,301 | |
11/21/2024 | 2,934 | 2,966 | 2,902 | 2,946 | 107,444 | |
11/20/2024 | 2,934 | 2,934 | 2,934 | 2,934 | 1.00 | |
11/19/2024 | 2,889 | 2,965 | 2,880 | 2,934 | 51,668 | |
11/18/2024 | 2,860 | 2,910 | 2,850 | 2,889 | 60,434 | |
11/14/2024 | 2,795 | 2,875 | 2,793 | 2,860 | 71,481 | |
11/13/2024 | 2,812 | 2,919 | 2,756 | 2,825 | 95,540 | |
11/12/2024 | 2,857 | 2,911 | 2,800 | 2,838 | 111,457 | |
11/11/2024 | 2,855 | 2,876 | 2,816 | 2,857 | 91,658 | |
11/08/2024 | 2,987 | 3,014 | 2,850 | 2,864 | 154,984 | |
11/07/2024 | 3,130 | 3,130 | 2,967 | 2,986 | 102,742 | |
11/06/2024 | 3,125 | 3,147 | 3,072 | 3,116 | 82,947 | |
11/05/2024 | 2,974 | 3,097 | 2,974 | 3,084 | 203,240 | |
11/04/2024 | 3,061 | 3,072 | 2,938 | 2,958 | 69,845 | |
11/01/2024 | 3,045 | 3,100 | 3,033 | 3,058 | 18,226 | |
10/31/2024 | 2,970 | 3,152 | 2,964 | 3,037 | 236,230 | |
10/30/2024 | 2,898 | 3,010 | 2,898 | 2,970 | 126,525 | |
10/29/2024 | 2,933 | 2,953 | 2,854 | 2,898 | 121,699 | |
10/28/2024 | 2,916 | 2,957 | 2,875 | 2,896 | 87,987 | |
10/25/2024 | 2,924 | 3,052 | 2,924 | 2,943 | 67,582 | |
10/24/2024 | 2,935 | 3,000 | 2,919 | 2,944 | 91,327 | |
10/23/2024 | 2,956 | 2,983 | 2,894 | 2,920 | 77,620 | |
10/22/2024 | 3,123 | 3,132 | 2,912 | 2,951 | 167,011 | |
10/21/2024 | 3,186 | 3,187 | 3,093 | 3,112 | 43,713 | |
10/18/2024 | 3,204 | 3,204 | 3,128 | 3,171 | 62,004 | |
10/17/2024 | 3,309 | 3,364 | 3,191 | 3,207 | 74,767 | |
10/16/2024 | 3,270 | 3,358 | 3,234 | 3,309 | 190,912 | |
10/15/2024 | 3,230 | 3,315 | 3,218 | 3,270 | 141,100 | |
10/14/2024 | 3,315 | 3,315 | 3,212 | 3,228 | 115,030 | |
10/11/2024 | 3,305 | 3,345 | 3,283 | 3,315 | 108,015 | |
10/10/2024 | 3,300 | 3,354 | 3,270 | 3,315 | 145,658 | |
10/09/2024 | 3,396 | 3,397 | 3,326 | 3,344 | 258,936 | |
10/08/2024 | 3,222 | 3,396 | 3,176 | 3,364 | 374,293 | |
10/07/2024 | 3,324 | 3,360 | 3,241 | 3,280 | 307,650 | |
10/04/2024 | 3,310 | 3,320 | 3,225 | 3,295 | 224,164 | |
10/03/2024 | 3,215 | 3,346 | 3,147 | 3,321 | 209,254 | |
10/01/2024 | 3,189 | 3,254 | 3,132 | 3,224 | 76,680 | |
09/30/2024 | 3,262 | 3,309 | 3,162 | 3,173 | 181,933 | |
09/27/2024 | 3,127 | 3,375 | 3,118 | 3,303 | 182,775 | |
09/26/2024 | 3,225 | 3,225 | 3,104 | 3,155 | 142,773 | |
09/25/2024 | 3,170 | 3,238 | 3,119 | 3,209 | 101,699 | |
09/24/2024 | 3,078 | 3,260 | 3,039 | 3,194 | 215,614 | |
09/23/2024 | 3,141 | 3,150 | 3,058 | 3,078 | 100,195 | |
09/20/2024 | 3,210 | 3,210 | 3,090 | 3,103 | 119,556 | |
09/19/2024 | 3,106 | 3,196 | 3,095 | 3,170 | 140,616 | |
09/18/2024 | 3,121 | 3,144 | 3,062 | 3,093 | 134,622 | |
09/17/2024 | 3,159 | 3,166 | 3,069 | 3,121 | 172,443 | |
09/16/2024 | 3,309 | 3,312 | 3,122 | 3,137 | 127,205 | |
09/13/2024 | 3,380 | 3,419 | 3,235 | 3,296 | 198,166 | |
09/12/2024 | 3,379 | 3,454 | 3,350 | 3,361 | 138,694 | |
09/11/2024 | 3,385 | 3,446 | 3,349 | 3,360 | 205,612 | |
09/10/2024 | 3,269 | 3,442 | 3,269 | 3,396 | 378,239 | |
09/09/2024 | 3,290 | 3,309 | 3,203 | 3,267 | 113,082 | |
09/06/2024 | 3,315 | 3,379 | 3,262 | 3,320 | 255,583 | |
09/05/2024 | 3,221 | 3,349 | 3,215 | 3,300 | 288,675 | |
09/04/2024 | 3,141 | 3,246 | 3,124 | 3,200 | 228,403 | |
09/03/2024 | 3,174 | 3,218 | 3,117 | 3,147 | 99,491 | |
09/02/2024 | 3,214 | 3,229 | 3,163 | 3,173 | 58,916 |
About Ajanta Pharma Stock history
Ajanta Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ajanta is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ajanta Pharma Limited will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ajanta Pharma stock prices may prove useful in developing a viable investing in Ajanta Pharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 126 M | 104.9 M | |
Net Income Applicable To Common Shares | 6.8 B | 5.2 B |
Ajanta Pharma Quarterly Net Working Capital |
|
Ajanta Pharma Stock Technical Analysis
Ajanta Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Ajanta Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ajanta Pharma's price direction in advance. Along with the technical and fundamental analysis of Ajanta Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ajanta to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0017 | |||
Jensen Alpha | (0.02) | |||
Total Risk Alpha | (0.36) | |||
Treynor Ratio | 1.07 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Ajanta Stock analysis
When running Ajanta Pharma's price analysis, check to measure Ajanta Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ajanta Pharma is operating at the current time. Most of Ajanta Pharma's value examination focuses on studying past and present price action to predict the probability of Ajanta Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ajanta Pharma's price. Additionally, you may evaluate how the addition of Ajanta Pharma to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |